Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Correlation of apparent diffusion coefficient ratio on 3.0 T MRI with prostate cancer Gleason score

Loading...
Thumbnail Image

Authors

Jyoti, Rajeev
Jain, Tarun Pankaj
Haxhimolla, Hodo
Liddell, Heath
Barrett, Sean Edward

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier B.V

Abstract

Introduction: The purpose was to investigate the usefulness of ADCratio on Diffusion MRI to discriminate between benign and malignant lesions of Prostate. Methods: Images of patients who underwent in-gantry MRI guided prostate lesion biopsy were retrospectively analyzed. Prostate Cancers with 20% or more Gleason score (GS) pattern 3+3=6 in each core or any volume of higher Gleason score pattern were included. ADCratio was calculated by two reviewers for each lesion. The ADCratio was calculated for each lesion by dividing the lowest ADC value in a lesion and highest ADC value in normal prostate in peripheral zone (PZ). ADCratio values were compared with the biopsy result. Data was analysed using independent samples T-test, Spearman correlation, intra-class correlation coefficient (ICC) and Receiver operating characteristic (ROC) curve. Results: 45 lesions in 33 patients were analyzed. 12 lesions were in transitional zone (TZ) and 33 in perpheral zone PZ. All lesions demonstrated an ADCratio of 0.45 or lower. GS demonstrated a negative correlation with both the ADC value and ADCratio. However, ADCratio (p < 0.001) demonstrated a stronger correlation compared to ADC value alone (p=0.014). There was no significant statistical difference between GS 3+4 and GS 4+3 mean ADCtumour value (p=0.167). However when using ADCratio, there was a significant difference (p=0.032). ROC curve analysis demonstrated an area under the curve of 0.83 using ADCratio and 0.76 when using ADCtumour value when discriminating Gleason 6 from Gleason ≥7 tumours. Inter-observer reliability in the calculation of ADC ratios was excellent, with ICC of 0.964. Conclusion: ADCratio is a reliable and reproducible tool in quantification of diffusion restriction for clinically significant prostate cancer foci.

Description

Citation

Source

European Journal of Radiology Open

Book Title

Entity type

Access Statement

Open Access

License Rights

Restricted until

abcd